Jessica L. Caro

Jessica L. Caro

Hematology Oncology | Hematology | Oncology

450 Lakeville Road
Entrance B
Lake Success, NY 11042

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 19 publications

Transdifferentiation of Multiple Myeloma into Histiocytic Sarcoma: Case Report of a Highly Unusual Phenomenon.

Transdifferentiation of Multiple Myeloma into Histiocytic Sarcoma: Case Report of a Highly Unusual Phenomenon.

Journal: Pathobiology : journal of immunopathology, molecular and cellular biology

Published: April 26, 2025

Real-world safety and efficacy of teclistamab in relapsed/refractory multiple myeloma: results from a multicenter, retrospective study and descriptive meta-analysis.

Real-world safety and efficacy of teclistamab in relapsed/refractory multiple myeloma: results from a multicenter, retrospective study and descriptive meta-analysis.

Journal: Leukemia & lymphoma

Published: January 05, 2025

Analysis of Updates in Multiple Myeloma Treatment and Management.

Analysis of Updates in Multiple Myeloma Treatment and Management.

Journal: Journal of clinical haematology

Published: November 27, 2023

Impact of Fluoroquinolone Prophylaxis on Neutropenic Fever, Infections, and Antimicrobial Resistance in Newly Diagnosed AML Patients.

Impact of Fluoroquinolone Prophylaxis on Neutropenic Fever, Infections, and Antimicrobial Resistance in Newly Diagnosed AML Patients.

Journal: Clinical lymphoma, myeloma & leukemia

Published: June 07, 2022

Inflammation and infection in plasma cell disorders: how pathogens shape the fate of patients.

Inflammation and infection in plasma cell disorders: how pathogens shape the fate of patients.

Journal: Leukemia

Published: November 02, 2021

Two-dimensional multiplexed assay for rapid and deep SARS-CoV-2 serology profiling and for machine learning prediction of neutralization capacity.

Two-dimensional multiplexed assay for rapid and deep SARS-CoV-2 serology profiling and for machine learning prediction of neutralization capacity.

Journal: bioRxiv : the preprint server for biology

Published: August 10, 2021

New approaches to managing relapsed/refractory Hodgkin lymphoma: the role of checkpoint inhibitors and beyond.

New approaches to managing relapsed/refractory Hodgkin lymphoma: the role of checkpoint inhibitors and beyond.

Journal: Expert review of hematology

Published: August 05, 2021

Impact of Etiological Cytogenetic Abnormalities on the Depth of Immunoparesis and Survival in Newly Diagnosed Multiple Myeloma.

Impact of Etiological Cytogenetic Abnormalities on the Depth of Immunoparesis and Survival in Newly Diagnosed Multiple Myeloma.

Journal: Clinical lymphoma, myeloma & leukemia

Published: June 30, 2021

Impaired Humoral Immunity to SARS-CoV-2 Vaccination in Non-Hodgkin Lymphoma and CLL Patients.

Impaired Humoral Immunity to SARS-CoV-2 Vaccination in Non-Hodgkin Lymphoma and CLL Patients.

Journal: medRxiv : the preprint server for health sciences

Published: June 08, 2021

How to Treat High-Risk Myeloma at Diagnosis and Relapse.

How to Treat High-Risk Myeloma at Diagnosis and Relapse.

Journal: American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting

Published: May 19, 2021

Case Report: Two Cases of Cryptosporidiosis in Heavily Pretreated Patients With Myeloma.

Case Report: Two Cases of Cryptosporidiosis in Heavily Pretreated Patients With Myeloma.

Journal: Clinical lymphoma, myeloma & leukemia

Published: December 17, 2020

Improving prognostic assignment in older adults with multiple myeloma using acquired genetic features, clonal hemopoiesis and telomere length.

Improving prognostic assignment in older adults with multiple myeloma using acquired genetic features, clonal hemopoiesis and telomere length.

Journal: Leukemia

Published: December 16, 2020

Showing 1-12 of 19

Last Updated: 09/26/2026